Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
US12312375B2 · kind B2 · utility
0Cited by
136References
30Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 9, 2024 |
| Grant date | May 27, 2025 |
| Priority date | — |
| Expiry date | Jul 9, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to the large-scale production of psilocybin for use in medicine. More particularly, it relates to a method of obtaining high purity crystalline psilocybin, particularly, in the form of Polymorph A. It further relates to a method for the manufacture of psilocybin and intermediates in the production thereof and formulations containing psilocybin.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.